Aspire Private Capital »

Cns Pharmaceuticals shares owned by Aspire Private Capital

Quarter-by-quarter ownership of Cns Pharmaceuticals (CNSP) shares owned by Aspire Private Capital from 13F filings

Historical chart of Aspire Private Capital investment in Cns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Cns Pharmaceuticals held by Aspire Private Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cns Pharmaceuticals by Aspire Private Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $52 400 0.13

More positions owned by Aspire Private Capital

Ssga Active Tr Spdr Ssga Fxd (FISR)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Spdr Ser Tr Portfolio Agrgte (SPAB)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
Vanguard Index Fds Value Etf (VTV)
Spdr Index Shs Fds Portfolio Emg Mk (SPEM)
Ssga Active Tr Spdr Ssga Us Sct (XLSR)
Vanguard Charlotte Fds Total Int Bd Etf (BNDX)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)

View all positions for Aspire Private Capital

Top funds holding Cns Pharmaceuticals

Geode Capital Management
Virtu Financial
Jane Street
Aspire Private Capital
Bank of America Corporation
Tower Research Capital
Wells Fargo & Company
Morgan Stanley
Global Retirement Partners
Northwestern Mutual Wealth Management Company
Plante Moran Financial Advisors
Parallel Advisors

View all funds holding Cns Pharmaceuticals